Introduction:

Nucleic Acid Labelling market accounted for US$ 1.73 billion in 2020 and is estimated to be US$ 3.11 billion by 2030 and is anticipated to register a CAGR of 6.1%.

Nucleic acids are large and complex molecules responsible for transfer of genetic information from one generation to the next. The two major types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA carries out the function of transmission of hereditary characters, while RNA is responsible for protein synthesis. Generally, nucleic acids are labelled with tags which enable the detection and purification processes. There are various chemical and enzymatic methods available for labeling nucleic acids, such as incorporation of fluorescent tags, radioactive phosphates, and modifications with biotin, which are primarily utilized in biotechnology applications.

The growth of nucleic acid labelling market is attributed to factors like increasing expenditure for health care, increasing funding for R&D in genomics and disease diagnosis, and increasing demand for personalized healthcare. In addition, rise in the investments on research and development centers to introduce new products is the key driving factor for the target market to grow. Increasing focus on the genomics is propelling the demand of the target market globally. Growing initiatives by public and private organizations are accelerating the growth of the nucleic acid labelling market. Increasing prevalence for the design of synthetic genome through different technologies available in the biotechnology field is solely to fuel the demand of the target market. However, stringent rules and regulations by the government in approving newly manufactured reference products is limiting the growth of the market. Lack of skilled person in monitoring the procedures is also restricting the demand of the market. Cost installation and maintenance equipment is a bit high and is remained a challenging thing for the target market developers. Increasing support from the government by changing schemes in favor of the common people is anticipated to present growth opportunities for the players in the target market. Furthermore, the market is let by shifting people interest in personalized medicine.

The global nucleic acid labelling market is segmented based on product, technique, application, and region.

Based on product, the global nucleic acid labelling market is segmented into biotin-based, fluorescent, radioactive, and others. Radioactive labels are the most preferred labels; however, demand for non-radioactive labels is increasing due to significant improvement in existing detection methods in terms of speed, versatility, and sensitivity. Based on the technique, the target market is segmented into PCR, nick translation, random primer, and others. PCR labelling technique is moving forward with the largest shares of the market. Based on application, the target market is bifurcated into DNA sequencing, FISH, microarray, and others. On the application basis, DNA sequencing application type is having the largest shares of the market. Arising number of genetic disease is broadening the demand of the market.

Region:

Based on the region the nucleic acid labelling market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts highest revenue share to the nucleic acid labelling market due to growing demand for advanced medical technologies and increasing geriatric population. Asia Pacific nucleic acid labelling market is projected to register a high CAGR over the forecast period owing to the growing trend of increase health care expenditure, personalized medicine treatments, and increase in research and development expenditure especially in genomic research and disease diagnosis.

         

Report Scope:

Attribute	Details
Base year for estimation	2020
Forecast period	2020 – 2030
Market representation	Revenue in USD billion & CAGR from 2020 – 2030
Market Segmentation	By Product - Biotin-based, Fluorescent, Radioactive and Others By Technique- PCR, Nick Translation, Random Primer and Others By Application– DNA Sequencing, FISH, Microarray and Others
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

 

Nucleic Acid Labelling Market, By Product:

• Biotin-based
• Fluorescent
• Radioactive
• Others

Nucleic Acid Labelling Market, By Technique:

• PCR
• Nick Translation
• Random Primer
• Others

Nucleic Acid Labelling Market, By Application:

• DNA Sequencing
• FISH
• Microarray
• Others

Nucleic Acid Labelling Market, By Region:

 

• North America
  • Middle East & Africa
    • Middle East & Africa Nucleic Acid Labelling  Market, By Product
    • Middle East & Africa Nucleic Acid Labelling  Market, By Technique
    • Middle East & Africa Nucleic Acid Labelling  Market, By Application
    • Middle East & Africa Nucleic Acid Labelling  Market, By Country
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • Latin America Nucleic Acid Labelling  Market, By Product
    • Latin America Nucleic Acid Labelling  Market, By Technique
    • Latin America Nucleic Acid Labelling  Market, By Application
    • Latin America Nucleic Acid Labelling  Market, By Country
      • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • Asia Pacific Nucleic Acid Labelling  Market, By Product
    • Asia Pacific Nucleic Acid Labelling  Market, By Technique
    • Asia Pacific Nucleic Acid Labelling  Market, By Application
    • Asia Pacific Nucleic Acid Labelling  Market, By Country
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • Europe Nucleic Acid Labelling  Market, By Product
    • Europe Nucleic Acid Labelling  Market, By Technique
    • Europe Nucleic Acid Labelling  Market, By Application
    • Europe Nucleic Acid Labelling  Market, By Country
      • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • North America Nucleic Acid Labelling  Market, By Product
  • North America Nucleic Acid Labelling  Market, By Technique
  • North America Nucleic Acid Labelling  Market, By Application
  • North America Nucleic Acid Labelling  Market, By Country
    • U.S.
    • Canada

The key players operating the nucleic acid labelling market involves Thermo Fisher Scientific Inc, Promega Corporation., PerkinElmer Inc, New England Biolabs, Merck KGaA, General Electric, F. Hoffman-La Roche AG, Enzo Biochem, Inc, Agilent Technologies, Inc., and Jena Bioscience GmbH. In July 2018, Creative Bioarrray launched a range of chromosome probes for genome amplification and translation. In july 2018, New England Biolabs Launched new NEBNext single cell/low –input RNA library prep kit for increased transcript detection with ultra-low input amounts.

• Thermo Fisher Scientific Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Product Portfolio
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Promega Corporation.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• PerkinElmer Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Product Portfolio
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• New England Biolabs
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Product Portfolio
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Merck KGaA
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Product Portfolio
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• General Electric.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• F. Hoffman-La Roche AG
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Industry Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Preview
   • Executive Summary
   • Key Findings—Global Outlook for Nucleic Acid Labelling Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Products
     • Market Snippet, By Technique
     • Market Snippet, By Application
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Market Segmentation, By Products, 2020 – 2030, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Biotin-based
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Fluorescent
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Radioactive
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Others
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
6. Market Segmentation, By Technique, 2020 – 2030, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • PCR
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Nick Translation
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Random Primer
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Others
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
7. Market Segmentation, By Application, 2020 – 2030, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • DNA Sequencing
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • FISH
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Microarray
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Others
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
8. Global Market, By Region, 2020 – 2030, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Bn), By Products, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Technique, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Bn), By Products, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Technique, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
       • Germany
       • UK
       • France
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Bn), By Products, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Technique, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
       • China
       • India
       • Japan
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast (US$ Bn), By Products, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Technique, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
       • Brazil
       • Mexico
       • Rest of Latin America
   • Middle East & Africa
     • Market Size and Forecast (US$ Bn), By Products, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Technique, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
       • GCC
       • Israel
       • South Africa
       • Rest of Middle East
9. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
10. Company Profiles
    •  
      • Thermo Fisher Scientific Inc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Promega Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • PerkinElmer Inc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • New England Biolabs
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Merck KGaA
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • General Electric
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • F. Hoffman-La Roche AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Enzo Biochem
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Agilent Technologies
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Jena Bioscience GmbH
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
11. The Last Word
    • Future Impact
    • About Us
    • Contact